Abstract:Objective: To analyse errors relating to the process of prescription, validation, preparation, dispensing and administration of cytostatic drugs, set out in the risk management programme regarding cytostatic drugs at our hospital. Methods: Prospective, descriptive and cross-sectional study, of three-year duration (2003-2005) on the total number of errors reported in the chemotherapy risk management programme.The dosing of cytostatic drugs is centralised in the Pharmacy Department, which prepared an average of 12,966 cytostatic preparations per annum during the study period. The prescription validation procedure for chemotherapy is therefore centralised at the Pharmacy Department and is the responsibility of the area pharmacist who detects the majority of prescription errors and keeps a record of all the errors detected in the circuit. Most chemotherapy dosing errors are detected when the preparations are checked prior to dispensing. Pharmaceutical validation errors are detected in the clinical units after the checking of the prescription by the nursing staff and administration errors are gathered through voluntary communication by nursing staff or, occasionally, by the patients themselves. The classification used for errors "by error type" is in accordance with the Spanish adaptation of the National Coordinating Causal for Medication Error Reporting and Prevention prepared by Otero. The qualitative variables analysed were measured as rates and/or percentages. Results: During the study period (between 2003-2005), 268 errors were reported, 87.91% of which were detected in the medical day hospital. An increase in errors was seen in 2005, affecting 13.91% of the patients as opposed to 6.69% and 4.81% in the years 2003 and 2004. The largest number of errors was reported by the nursing staff (54.08%) followed by the pharmacist with 39.55% and the doctor 4.47%. Prescription errors (45.14%) were the most frequent, followed by validation (33.58%) and preparation (16.41%) errors. Among the prescription errors, the greatest percentages correspond to underdosing (32.32%), overdosing (16.16%) and dose reversal (11.11%). A total of 11.94% (32) of these reached the patient and 88.06% were prevented. Conclusions: The assessment of care practices and the critical, constructive analysis of the errors detected therein can be used as a tool that will enable the continuous improvement of procedures and the increased clinical safety of the patients. The collaboration of all the personnel involved in the circuits with known and shared objectives can enable a more exact dimension to be obtained of our current care situation in aspects for the clinical safety of patients.

Clinical pharmacy in onco-hematology and bone marrow transplant: A valuable contribution to improving patient safety

Analysis of pharmaceutical interventions in chemotherapy prescriptions of adult and pediatric patients at an oncology reference institute

Implementation of Pharmacists' Interventions and Assessment of Medication Errors in an Intensive Care Unit of A Chinese Tertiary Hospital

Clinical Pharmacist Interventions on a Chinese Neurology Ward: a 2-Year Service Evaluation

Impact of clinical pharmacy in oncology and hematology centers: A systematic review

Safe Medication Use Based on Knowledge of Information about Contraindications Concerning Cross Allergy and Comprehensive Clinical Intervention

Prescribing errors involving antineoplastics and others drug centre of preparation of injectable drugs

An Evaluation of Clinical Pharmacist Service on a Neurology Care Unit.

[Analysis of the errors associated with the prescription, preparation and administration of cytostatic drugs]

Qualitative analysis of clinical pharmacy interventions in an inpatient leukemia service

Improving medication safety in oncology care: impact of clinical pharmacy interventions on optimizing patient safety

Prescribing errors in a Brazilian teaching hospital: Causes and underlying factors from the perspective of junior doctors

Analysis of clinical pharmacist interventions in the neurology unit of a Brazilian tertiary teaching hospital

Evaluation of the implementation of a clinical pharmacy service on an acute internal medicine ward in Italy

EVALUATION OF PHARMACISTS' IMPACT ON HEMATOLOGY ONCOLOGY CHEMOTHERAPY ORDERS

Implementation of clinical pharmacy services in an academic oncology practice in India

Impact of medication therapy management on pharmacotherapy safety in an intensive care unit

Impact of pharmaceutical validation on prescribing errors in a neonatal intensive care unit. Randomised and controlled study

Impact of the COVID-19 Pandemic on Pharmacist Interventions: A Retrospective Study with Inpatients in a University Hospital

Effects of multidisciplinary teams and an integrated follow-up electronic system on clinical pharmacist interventions in a cancer hospital

Improving medication safety in a Latin American hospital: Examination of medication errors and the role of pharmacists